US OKs first drug for dyskinaesia in Parkinson’s patients
US regulators have approved the first and only treatment option to treat dyskinaesia in patients with Parkinson’s disease.
Read More
Tag: Gocovri
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
